Results 101 to 110 of about 206,609 (179)

The problematic history of randomised controlled trials Part 3: Mainland, Hill and the future of RCTs. [PDF]

J R Soc Med
Matthews RA.
europepmc   +1 more source

Concerns Regarding Masataka et al.'s "Revisiting the Gateway Drug Hypothesis for Cannabis: A Secondary Analysis of a Nationwide Survey Among Community Users in Japan". [PDF]

Neuropsychopharmacol Rep
Narita ZC.
europepmc   +1 more source

Counting particles in cryo-electron microscopy may result in incorrect population estimates. [PDF]

Commun Biol
Evans L, Dingeldein L, Covino R, Gilles MA, Thiede E, Cossio P.   +5 more
europepmc   +1 more source

Factors associated with: problems of using exploratory multivariable regression to identify causal risk factors. [PDF]

BMJ Med
Lewer D, Brothers T, O'Nions E, Pickavance J.   +3 more
europepmc   +1 more source

Irrationality in humans and creativity in AI. [PDF]

Front Artif Intell
Sobetska O.
europepmc   +1 more source

INTEGRATIVE ECOLOGICAL REGRESSION ANALYSIS OF U.S. COUNTY AND STATE LEVEL COVID-19 DEATH DATA FOR STUDYING HEALTH DISPARITY ASSOCIATIONS. [PDF]

Ann Appl Stat
Li D, Lin X.
europepmc   +1 more source

The Metric Fallacy [PDF]

Science, 1905
openaire   +3 more sources

Dissecting the difference between positive and negative brain health sentiment using X data. [PDF]

Front Digit Health
Religa P, Mickael ME, Łazarczyk M, Kubick N, Rehan IF, Horbańczuk JO, Elnagar A, Sacharczuk M, Atanasov AG.   +8 more
europepmc   +1 more source

The problematic history of randomised controlled trials Part 2: Hill's 'pragmatic' view of randomisation and its origins. [PDF]

J R Soc Med
Matthews RA.
europepmc   +1 more source

Unconscious cognition without post hoc selection artifacts: From selective analysis to functional dissociations. [PDF]

Behav Res Methods
Schmidt T, Wolkersdorfer MP, Lee XY, Jubran O.   +3 more
europepmc   +1 more source